EVEREST MED-B: Notification Letter with Request Form to Non-registered Holders
Apr 24 10:01 ET
EVEREST MED-B: Notification Letter with Change Request Form to Registered Shareholders
Apr 24 09:59 ET
EVEREST MED-B: 2023 Environmental, Social and Governance Report
Apr 24 09:55 ET
EVEREST MED-B: 2023 Annual Report
Apr 24 09:51 ET
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 8 04:30 ET
EVEREST MED-B: (1) GRANT OF OPTIONS (2) GRANT OF AWARDS (3) NON-EXEMPTED CONNECTED TRANSACTIONS - PROPOSED AWARD GRANTS TO CONNECTED PERSONS
Apr 5 10:29 ET
EVEREST MED-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Mar 27 18:45 ET
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT VOLUNTARY LOCK-UP UNDERTAKING BY CONTROLLING SHAREHOLDER AND CERTAIN SENIOR MANAGEMENT
Mar 17 18:55 ET
EVEREST MED-B: DATE OF BOARD MEETING
Mar 5 18:03 ET
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 5 06:54 ET
EVEREST MED-B: UPDATE IN RELATION TO DISCLOSEABLE TRANSACTION - (1) COLLABORATION AND LICENSE AGREEMENT; AND (2) SHARE ISSUANCE AGREEMENT IN RESPECT OF THE MANUFACTURE, DEVELOPMENT AND COMMERCIALIZATION OF COVID-19 VACCINES AND CERTAIN LICENSED PRODUCTS
Feb 18 18:50 ET
EVEREST MED-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Feb 9 02:49 ET
EVEREST MED-B: CHANGE OF NON-EXECUTIVE DIRECTOR
Feb 9 02:48 ET
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 6 05:22 ET
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE
Jan 21 17:56 ET
EVEREST MED-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Jan 12 04:05 ET
EVEREST MED-B: CHANGE OF NON-EXECUTIVE DIRECTOR
Jan 12 04:02 ET
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 5 04:46 ET
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Dec 6, 2023 05:52 ET
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE APPROVAL OF NEW DRUG APPLICATION IN CHINA FOR NEFECON FOR THE TREATMENT OF PRIMARY IMMUNOGLOBULIN A NEPHROPATHY IN ADULTS AT RISK OF DISEASE PROGRESSION
Nov 23, 2023 23:00 ET
No Data
No Data